Search Within

Larry Wayne Buie

Formats
  1. Meeting Abstract (14)
  2. Journal Article (10)
  3. Review (1)
Groups
  1. Department of Medicine (18)
  2. Clinical Pharmacy Specialists (15)
  3. Hematologic Malignancies, Division of (14)
  4. Center for Hematologic Malignancies (11)
  5. Biostatistics Service (9)
  6. Epidemiology and Biostatistics (9)

More Groups

People
  1. Ryan Daley (7)
  2. Sean Devlin (6)
  3. Troy Horvat (6)
  4. Josiah Land (5)
  5. Dan Douer (4)
  6. Dazhi Liu (4)

More People

Years
  1. 2022 (3)
  2. 2021 (3)
  3. 2020 (3)
  4. 2019 (5)
  5. 2018 (2)
  6. 2017 (4)

More Years

Publications
  1. Blood (7)
  2. Biology of Blood and Marrow Transplantation (3)
  3. Annals of Pharmacotherapy (2)
  4. Journal of Oncology Pharmacy Practice (2)
  5. American Journal of Managed Care (1)
  6. Annals of Hematology (1)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. Elsevier Inc. (4)
  3. American Society of Clinical Oncology (3)
  4. Nature Publishing Group (2)
  5. Sage Publications (2)
  6. Sage Publications Ltd. (2)

More Publishers

Results (25)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: An international survey of oncology pharmacy practitioners
    Journal Article

    Chazan, G.; Jupp, J.; Bauters, T.; Duncan, N.; Weddle, K. J.; Nomura, H.; O'Connor, S.; Chan, A.; Alkhudair, N.; Alshamrani, M.; more...
    Journal of Oncology Pharmacy Practice (2022)

    Fulltext@MSK | Save
  • National survey on the effect of oncology drug shortages in clinical practice: A hematology oncology pharmacy association survey
    Journal Article

    McBride, A.; Hudson-DiSalle, S.; Pilz, J.; Hamm, M.; Boring, B.; Buie, L. W.; DeRemer, D. L.
    JCO Oncology Practice (2022)

    Fulltext@MSK | Save
  • Immune biomarkers and response to checkpoint inhibition of BRAF(V600) and BRAF non-V600 altered lung cancers
    Journal Article

    Murciano-Goroff, Y. R.; Pak, T.; Mondaca, S.; Flynn, J. R.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Plodkowski, A. J.; Wu, S. L.; Kris, M. G.; more...
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • National survey on the effect of oncology drug shortages in clinical practice: A Hematology Oncology Pharmacy Association (HOPA) survey
    Meeting Abstract

    Hudson-Disalle, S.; DeRemer, D. L.; Buie, L. W.; Hamm, M.; Pilz, J.; McBride, A.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Balancing the CAR T: Perspectives on efficacy and safety of CAR T-cell therapy in hematologic malignancies
    Review

    Buie, L. W.
    American Journal of Managed Care (2021)

    Fulltext@MSK | Save
  • Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City
    Journal Article

    Yerram, P.; Thackray, J.; Modelevsky, L. R.; Land, J. D.; Reiss, S. N.; Spatz, K. H.; Levoir, A. C.; Pak, T. K.; Dao, P. H.; Buege, M. J.; more...
    Journal of Oncology Pharmacy Practice (2021)

    Fulltext@MSK | Save
  • Conditioning regimen comparison for allogeneic stem cell transplantation in non-Hodgkin lymphoma
    Meeting Abstract

    Peterson, K.; Lin, A.; Ruiz, J.; Zheng, J.; Devlin, S.; Shah, G.; Scordo, M.; Sauter, C.; Perales, M.; Giralt, S.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Comparison of conditioning regimens for allogeneic hematopoietic cell transplantation in non-Hodgkin lymphoma
    Meeting Abstract

    Peterson, K. T.; Lin, A.; Ruiz, J. D.; Zheng, J.; Devlin, S. M.; Shah, G. L.; Scordo, M.; Sauter, C. S.; Perales, M.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Correlation of IL-6 secretion and hyponatremia with the use of CD19+ chimeric antigen receptor T-cells
    Journal Article

    Dixon, B. N.; Daley, R. J.; Buie, L. W.; Hsu, M.; Park, J. H.; Brentjens, R. J.; Purdon, T. J.; Latcha, S.
    Clinical Nephrology (2020)

    Fulltext@MSK | Save
  • VTE rates and safety analysis of newly diagnosed multiple myeloma patients receiving carfilzomib-lenalidomide-dexamethasone (KRD) with or without rivaroxaban prophylaxis
    Meeting Abstract

    Piedra, K. M.; Hassoun, H.; Buie, L. W.; Devlin, S. M.; Flynn, J.; Hultcrantz, M.; Lesokhin, A. M.; Lu, S. X.; Mailankody, S.; Shah, U. A.; more...
    Blood (2019)

    Fulltext@MSK | Save